Antibody neutralization of HIV-1 and the potential for vaccine design.

Antibody neutralization of HIV-1 and the potential for vaccine design.

Neutralisation by antibody is, for a number of viruses, an in vitro correlate for protection in vivo. For HIV-1 this is controversial. However, the induction of a potent anti-HIV neutralising antibody response remains one of the principal goals in vaccine development. A greater knowledge of the fund...

Full description

Bibliographic Details
Main Authors:	Sattentau, Q, Moulard, M, Brivet, B, Botto, F, Guillemot, J, Mondor, I, Poignard, P, Ugolini, S
Format:	Conference item
Published:	1999

Similar Items

Antibody neutralization of HIV-1.
by: Poignard, P, et al.
Published: (1996)

HIV-1-CD4-coreceptor interactions in virus binding and neutralization
by: Sattentau, Q, et al.
Published: (1998)

HIV-1 attachment: another look.
by: Ugolini, S, et al.
Published: (1999)

Neutralization of HIV-1 by antibody.
by: Sattentau, Q
Published: (1996)

Interactions among HIV gp120, CD4, and CXCR4: dependence on CD4 expression level, gp120 viral origin, conservation of the gp120 COOH- and NH2-termini and V1/V2 and V3 loops, and sensitivity to neutralizing antibodies.
by: Mondor, I, et al.
Published: (1998)

Inhibition of virus attachment to CD4+ target cells is a major mechanism of T cell line-adapted HIV-1 neutralization.
by: Ugolini, S, et al.
Published: (1997)

New templates for HIV-1 antibody-based vaccine design
by: Sattentau, Q, et al.
Published: (2010)

Antigenicity and Immunogenicity in HIV-1 Antibody-Based Vaccine Design.
by: Kong, L, et al.
Published: (2012)

Cell-to-cell spread of HIV-1 and evasion of neutralizing antibodies.
by: Schiffner, T, et al.
Published: (2013)

New templates for HIV-1 antibody-based vaccine design.
by: Sattentau, Q, et al.
Published: (2010)

HIV-1 gp120 induces an association between CD4 and the chemokine receptor CXCR4.
by: Ugolini, S, et al.
Published: (1997)

Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans.
by: Mondor, I, et al.
Published: (1998)

Neutralizing antibodies to human immunodeficiency virus type-1 gp120 induce envelope glycoprotein subunit dissociation.
by: Poignard, P, et al.
Published: (1996)

Selective HIV-1-induced downmodulation of CD4 and coreceptors.
by: Chenine, A, et al.
Published: (2000)

The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity.
by: Parren, P, et al.
Published: (1999)

Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design.
by: Parren, P, et al.
Published: (1997)

Epitope exposure on functional, oligomeric HIV-1 gp41 molecules.
by: Sattentau, Q, et al.
Published: (1995)

Erratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design".
by: Parren, P, et al.
Published: (1997)

The activity of a potent neutralizing human antibody against primary isolates in vivo
by: Burton, DR, et al.
Published: (1998)

Nanoparticle Vaccines for Inducing HIV-1 Neutralizing Antibodies
by: Mitch Brinkkemper, et al.
Published: (2019-07-01)

Mechanisms of virus neutralization by antibody.
by: Klasse, P, et al.
Published: (2001)

Conservation of HIV-1 gp120 neutralizing epitopes after formalin inactivation.
by: Sattentau, Q
Published: (1995)

Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
by: Haynes, BF, et al.
Published: (2022)

Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity.
by: Parren, P, et al.
Published: (1998)

Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design (vol 57, pg 105, 1997)
by: Parren, P, et al.
Published: (1997)

Antibody-based HIV-1 vaccines: recent developments and future directions
by: Montefiori, D, et al.
Published: (2007)

Antibody-based HIV-1 vaccines: recent developments and future directions.
by: Montefiori, D, et al.
Published: (2007)

HIV-1 antibody--debris or virion?
by: Parren, P, et al.
Published: (1997)

Occupancy and mechanism in antibody-mediated neutralization of animal viruses.
by: Klasse, P, et al.
Published: (2002)

Mechanisms of escape from the PGT128 family of anti-HIV broadly neutralizing antibodies
by: Krumm, S, et al.
Published: (2016)

Enhancement of soluble CD4-mediated HIV neutralization and gp 120 binding by CD4 autoantibodies and monoclonal antibodies.
by: Moore, J, et al.
Published: (1990)

High-multiplicity HIV-1 infection and neutralizing antibody evasion mediated by the macrophage-T cell virological synapse
by: Duncan, C, et al.
Published: (2014)

Elicitation of Neutralizing Antibody Responses to HIV-1 Immunization with Nanoparticle Vaccine Platforms
by: Amyn A. Murji, et al.
Published: (2021-07-01)

Correlates of antibody-mediated protection against HIV infection.
by: Sattentau, Q
Published: (2008)

Development of prophylactic vaccines against HIV-1.
by: Schiffner, T, et al.
Published: (2013)

IDIOTYPE VACCINES FOR HIV BASED ON CD4 ANTIBODIES
by: Sattentau, Q, et al.
Published: (1990)

Idiotype vaccines for HIV based on CD4 antibodies
by: Sattentau, Q, et al.
Published: (1990)

Structural and genetic convergence of HIV-1 neutralizing antibodies in vaccinated non-human primates.
by: Fangping Cai, et al.
Published: (2021-06-01)

Monoclonal antibodies to HIV-1 gp120: a request.
by: Moore, J, et al.
Published: (1993)

HIV-1 antibody - Debris or virion? (vol 3, pg 366, 1997)
by: Parren, P, et al.
Published: (1997)